|














.gif)
Learn more about Rapid
Test Technologies
|
|
SDI
is promoting the development and evaluation of diagnostics that
are ASSURED:
- Affordable
| -
by those at risk of infection |
- Sensitive
- Specific
- User-friendly:
|
- simple
to perform: 3-4 steps, with minimal training |
- Rapid
and Robust
|
- rapid: to enable treatment at first visit |
|
- robust: does not require refrigerated storage |
- Equipment-free
|
-
easily collected non-invasive specimens, e.g.
urine, saliva |
- Delivered
Current
priorities for SDI are the development and evaluation of
diagnostics for the following diseases:
| Disease |
Indication |
Ideal
specimen |
|
CHLAMYDIA
GONorrhoea
|
Screening of high risk
population
Support
of syndromic management in high and low disease prevalence
settings
|
Woman:
vaginal swab, urine
Man:
urine
|
| Syphilis |
Screening
of pregnant women
(to distinguish active from past
infection in endemic settings) |
Whole
blood, saliva |
See details in January
2001 meeting report
|
|
|
|
|
|